Stocks and Investing Stocks and Investing
Thu, March 11, 2021

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $130 on, Mar 11th, 2021


Published on 2024-10-27 15:54:47 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $126 to $130 on, Mar 11th, 2021.

Jayson has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Jayson's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $115 on, Saturday, February 6th, 2021


These are the ratings of the 6 analyists that currently disagree with Jayson


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $136 on, Thursday, January 28th, 2021
  • Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $140 on, Thursday, January 28th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $137 on, Thursday, January 28th, 2021
  • Marie Thibault of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $140 on, Thursday, January 28th, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, January 28th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy with Increased Target to $145 on, Thursday, January 28th, 2021
Contributing Sources